Moleculin Biotech, Inc. (MBRX)
NASDAQ: MBRX · Real-Time Price · USD
0.9591
-0.0145 (-1.49%)
At close: Apr 1, 2025, 4:00 PM
0.9625
+0.0034 (0.35%)
After-hours: Apr 1, 2025, 4:36 PM EDT
Moleculin Biotech Employees
Moleculin Biotech had 18 employees as of December 31, 2023. The number of employees decreased by 1 or -5.26% compared to the previous year.
Employees
18
Change (1Y)
-1
Growth (1Y)
-5.26%
Revenue / Employee
n/a
Profits / Employee
-$1,209,056
Market Cap
13.43M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
MBRX News
- 8 hours ago - Moleculin Doses First Patient in Pivotal, Adaptive Phase 3 MIRACLE Trial - GlobeNewsWire
- 8 days ago - Moleculin Biotech, Inc. (MBRX) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 8 days ago - Moleculin Reports Full Year 2024 Financial Results and Provides Corporate Update - GlobeNewsWire
- 13 days ago - Moleculin to Report Full Year 2024 Financial Results on March 21, 2025 and Host Conference Call and Webcast - GlobeNewsWire
- 21 days ago - Moleculin Biotech, Inc. Participates in the Virtual Investor "Top 5 for '25" On-Demand Conference - PRNewsWire
- 22 days ago - Moleculin to Present at the 37th Annual ROTH Conference - PRNewsWire
- 26 days ago - Moleculin Announces Additional Annamycin Patent Allowances to Enhance Global Exclusivity - PRNewsWire
- 4 weeks ago - Moleculin Abstract Accepted for Poster Presentation at the Acute Leukemias XIX (ISALXIX) International Symposium - PRNewsWire